Regression of necrotizing scleritis in Wegener's granulomatosis after infliximab treatment.
Kontkanen
Matti
M
Paimela
Leena
L
Kaarniranta
Kai
K
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D014890:Granulomatosis with Polyangiitis / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D000069285:Infliximab; D008297:Male; D015423:Scleritis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014792:Visual Acuity
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab